Most somatic mutations of the EGFR gene associated with lung adenocarcinoma cause abnormal expression of the KRAS gene, which can continuously activate the EGFR signaling pathway and eventually enhance cell proliferation, leading to the generation of cancer. This evidence concerns the gene EGFR and lung adenocarcinoma.